An α2-Adrenergic Agonist, Brimonidine, Beneficially Affects the TGF-β2-Treated Cellular Properties in an In Vitro Culture Model

We report herein on the effects of brimonidine (BRI), an α2-adrenergic agonist, on two-dimensional (2D) and three-dimensional (3D) cell-cultured TGF-β2-untreated and -treated human trabecular meshwork (HTM) cells. In the presence of TGF-β2 (5 ng/mL), (1) the effects of BRI on (1) the 2D HTM monolaye...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Megumi, Sato, Tatsuya, Tsugeno, Yuri, Higashide, Megumi, Furuhashi, Masato, Umetsu, Araya, Suzuki, Soma, Ida, Yosuke, Hikage, Fumihito, Ohguro, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312232/
https://www.ncbi.nlm.nih.gov/pubmed/35877361
http://dx.doi.org/10.3390/bioengineering9070310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312232/
https://www.ncbi.nlm.nih.gov/pubmed/35877361
http://dx.doi.org/10.3390/bioengineering9070310

Ejemplares similares